Eurobio Scientific acquired Surrey based Pathway Diagnostics Ltd in 2019. Pathway Diagnostics Ltd have been supplying haemostasis, immunology, quality control materials and infectious disease products as a distributor and manufacturer to the UK and Ireland IVD, research, and industrial markets since 1998, and has had a long-term commercial relationship with Eurobio Scientific prior to the acquisition.

Eurobio Scientific is a major player in the field of specialty in vitro diagnostics products, supplying into the diagnostics, research, transplantation, immunology, and infectious diseases, and industrial laboratories, including pharmaceutical and biotechnology companies. With numerous partnerships and a strong hospital presence, Eurobio Scientific has its own extensive distribution network and a portfolio of proprietary molecular biology products. The Eurobio Group has approximately 164 employees, three production units based in the Paris region, Germany and the USA, and subsidiaries in Surrey in the UK, Sissach in Switzerland, Bünde in Germany, and Utrecht in the Netherlands.

The Company is highly focused on the needs of its customers and in  providing the highest quality products and service. It has developed a  number of partnerships with Diagnostics manufacturers in order to supply  its customers with complete and innovative diagnostic solutions.

Eurobio Scientific UK also manufacturers its own range of haemostasis  tests and allergy, autoimmune and tryptase controls that are marketed  internationally through  local distributors or direct from the UK. The Company also operates its  independent PathQAS Quality Assurance schemes (PathQAS)  for Coagulation, Allergy, Autoimmune serology, Calprotectin and  Prekallikrein Activator assays, as a service to it's customers.